A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy

QR Code

A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy

Abstract The inadequate adherence of patients whose hyperlipidemia is treated with atorvastatin (ATR) to medical instructions presents a serious health risk. Our aim was to develop a flexible approach based on therapeutic drug monitoring (TDM), nonparametric population pharmacokinetic modeling, and...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Gellért Balázs Karvaly, István Karádi, István Vincze, Michael N. Neely, Eszter Trojnár, Zoltán Prohászka, Éva Imreh, Barna Vásárhelyi, András Zsáry
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	adherence atorvastatin metabolism nonparametric pharmacokinetic model pharmacokinetics therapeutic drug monitoring Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/e3277a6d16c34a73b9a26ecfca0b40fd
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
par: Ruben A. G. van Eerden, et autres
Publié: (2021)

Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects
par: Sejung Hwang, et autres
Publié: (2021)

Effect of Missed Doses on the Therapeutic Effect of Methotrexate for Rheumatoid Arthritis: A Pharmacokinetic Modeling Study
par: Morrison A, et autres
Publié: (2021)

Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies
par: Li Y, et autres
Publié: (2020)

Population Pharmacokinetics of CC-122
par: Cheng Y, et autres
Publié: (2021)

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
par: Wiederhold NP
Publié: (2015)

Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials
par: Vermunt M, et autres
Publié: (2021)

Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients
par: Amedeo De Nicolò, et autres
Publié: (2021)

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
par: Oh DA, et autres
Publié: (2017)

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
par: Li Y, et autres
Publié: (2017)

Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
par: Muhammad Muaaz Munir, et autres
Publié: (2021)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
par: Roganović Maša, et autres
Publié: (2021)

The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic Review
par: Sileshi T, et autres
Publié: (2021)

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
par: Tran JQ, et autres
Publié: (2016)

Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits
par: Alzoubi KH, et autres
Publié: (2018)

A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin
par: Goldwater R, et autres
Publié: (2016)

Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
par: Wang X, et autres
Publié: (2020)

Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
par: Rambiritch V, et autres
Publié: (2016)

Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
par: Saeed Alqahtani, et autres
Publié: (2021)

Mechanistic Computational Models of Epithelial Cell Transporters-the Adorned Heroes of Pharmacokinetics
par: Jasia King, et autres
Publié: (2021)

A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants
par: Li H, et autres
Publié: (2020)

Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity
par: Junqi Zhao, et autres
Publié: (2021)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
par: Frost C, et autres
Publié: (2018)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
par: Lan-hong Ruan, et autres
Publié: (2021)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique
par: Wang H, et autres
Publié: (2021)

Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
par: Yi Tao, et autres
Publié: (2021)

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
par: Andreas Port, et autres
Publié: (2021)

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
par: Kohama H, et autres
Publié: (2017)

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
par: Kreutz RP, et autres
Publié: (2016)

Identification and pharmacokinetics of bioavailable anti-resorptive phytochemicals after oral administration of Psoralea corylifolia L.
par: Ami Lee, et autres
Publié: (2021)

Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
par: Carlander U, et autres
Publié: (2016)

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
par: Peile Wang, et autres
Publié: (2021)

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
par: Mehta R, et autres
Publié: (2020)

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
par: Rambiritch V, et autres
Publié: (2016)

Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers
par: Naoto Noda, et autres
Publié: (2021)

Clinical Validation of a Volumetric Absorptive Micro-Sampling Device for Pharmacokinetic Studies With Tranexamic Acid
par: Stanislas Grassin-Delyle, et autres
Publié: (2021)

Recombinant human granulocyte-macrophage colony-stimulating factor: effect of glycosylation on pharmacokinetic parameters
par: Marini,Guillermo, et autres
Publié: (2007)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
par: Christoph Tiede, et autres
Publié: (2021)

Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
par: Mengfei Cheng, et autres
Publié: (2021)

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
par: Chuhui Wang, et autres
Publié: (2021)